4-羟基-6-甲基-喹啉-3-羧酸 | 35973-18-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4-羟基-6-甲基-喹啉-3-羧酸
• 中文别名: 4-羟基-6-甲基喹啉-3-羧酸
• 英文名称: 6-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• 英文别名: 6-methyl-4-oxo-1H-quinoline-3-carboxylic acid
• CAS: 35973-18-3
• 化学式: C₁₁H₉NO₃
• mdl: MFCD00454147
• 分子量: 203.197
• InChiKey: MBHYBSDKDMRZAA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2933499090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Hydroxy-6-methylquinoline-3-carboxylic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Hydroxy-6-methylquinoline-3-carboxylic acid
CAS number: 35973-18-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H9NO3
Molecular weight: 203.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-羟基-6-甲基-喹啉-3-羧酸 在 三甲基氯硅烷 、 三氟甲磺酸三甲基硅酯 、 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 18.0h， 生成 6-methyl-1,4-dihydro-4-oxo-1-(β-D-ribofuranosyl)quinoline-3-carboxylic acid
  参考文献：
  名称：

  具有抗 HSV-1 活性的喹诺酮核糖核苷的构象分析

  摘要：

  摘要 单纯疱疹病毒引起的感染是成人最常见的疾病来源之一，目前有几种天然核苷类似物用于治疗这些感染。我们小组部分合成的一系列喹诺酮核糖核苷衍生物的体外试验表明，其中一些对HSV-1具有抗病毒活性。生物活性化合物的构象分析对于更好地了解其化学结构和生物活性非常重要。在这项工作中，我们对 6-Me 核糖核苷衍生物进行了核弛豫 NMR 研究，以确定顺式或反式构象是优先的。NMR 分析允许通过使用基于核弛豫和相关现象的技术来确定原子间距离。这些技术是非选择性纵向或自旋晶格弛豫率和 NULL 脉冲序列，它们允许确定氢原子对之间的距离。将核磁共振研究的结果与通过分子模型获得的结果进行比较。

  DOI：

  10.1016/j.molstruc.2010.01.044
• 作为产物：
  描述：

  4-羟基-6-甲基喹啉-3-羧酸乙酯 在 sodium hydroxide 作用下， 反应 1.0h， 生成 4-羟基-6-甲基-喹啉-3-羧酸
  参考文献：
  名称：

  Preparation of Quinoline Hexose Analogs as Novel Chloroquine-Resistant Malaria Treatments (1). Synthesis of 4-Hydroxyquinoline-.BETA.-glucosides

  摘要：

  喹啉己糖类似物有望成为治疗耐氯喹疟疾的新型药物。在此，我们报告了通过 4 个步骤从苯胺制备 4-羟基喹啉-β-葡萄糖苷的过程。

  DOI：

  10.1248/cpb.55.821

文献信息

• MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
  申请人：Sheth Urvi

  公开号：US20120309758A1

  公开（公告）日：2012-12-06

  The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

  本发明涉及调节ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜传导调节蛋白，以及相关的组合物和方法。本发明还涉及使用这些调节剂治疗ABC转运蛋白介导的疾病的方法。
• Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat–TAR interaction inhibitors
  作者：Shuguang Chen、Ran Chen、Meizi He、Ruifang Pang、Zhiwu Tan、Ming Yang

  DOI：10.1016/j.bmc.2009.01.038

  日期：2009.3

  Thirty-two quinoline derivatives were designed and synthesized as HIV-1 Tat–TAR interaction inhibitors. All the compounds showed high antiviral activities in inhibiting the formation of SIV-induced syncytium in CEM174 cells. Nine of them with low cytotoxicities were evaluated by Tat dependent HIV-1 LTR-driven CAT gene expression colorimetric enzyme assay in human 293T cells, indicating effective inhibitory

  设计并合成了32种喹啉衍生物作为HIV-1 TAt-TAR相互作用抑制剂。所有这些化合物在抑制CEM174细胞中SIV诱导的合胞体形成方面均表现出很高的抗病毒活性。在人的293T细胞中，通过TAt依赖HIV-1 LTR驱动的CAT基因表达比色酶分析评估了其中9种低细胞毒性，表明它们具有有效的抑制TAt-TAR相互作用的抑制活性。分子模拟实验表明，这些化合物可能通过与TAt蛋白而非TAR RNA结合而抑制TAt-TAR相互作用。
• [EN] INDOLIZINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THERAPEUTIC USE THEREOF<br/>[FR] DÉRIVÉS DE L'INDOLIZINE, PROCÉDÉ POUR LEUR PRÉPARATION, ET LEUR UTILISATION THÉRAPEUTIQUE
  申请人：SANOFI SA

  公开号：WO2012004731A1

  公开（公告）日：2012-01-12

  The invention relates to compounds corresponding to formula (I): N R1 O R3 R4 R2 (I) in which - R3 and R4 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: N N O O Ra Ra' N N O Rb Rb' N O Rc Rc'' Rc' (A) (B) (C) in which the wavy lines represent the phenyl nucleus to which R3 and R4 are attached. Preparation process and therapeutic use.

  该发明涉及与以下式（I）相对应的化合物：N R1 O R3 R4 R2（I），其中- R3和R4与它们附着的苯环的碳原子一起形成一个与下面的式（A）、（B）或（C）之一相对应的6元氮杂环：N N O O Ra Ra' N N O Rb Rb' N O Rc Rc'' Rc'（A）（B）（C），其中波浪线代表R3和R4附着的苯环。制备过程和治疗用途。
• Modulators of ATP-Binding Cassette Transporters
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20130165442A1

  公开（公告）日：2013-06-27

  The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

  本发明涉及ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜电导调节器、其组成物以及使用它们的方法。本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
• INDOLIZINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
  申请人：Alcouffe Chantal

  公开号：US20130116249A1

  公开（公告）日：2013-05-09

  The invention relates to compounds corresponding to formula (I): in which R 3 and R 4 together form, with the carbon atoms of the phenyl nucleus to which they are attached, a 6-membered nitrogenous heterocycle corresponding to one of formula (A), (B) or (C) below: in which the wavy lines represent the phenyl nucleus to which R 3 and R 4 are attached. Preparation process and therapeutic use.

  本发明涉及与式(I)相对应的化合物： 其中，R3和R4与它们所连接的苯环的碳原子一起形成一个6元氮杂环，该环对应于下列式之一：(A)、(B)或(C)式： 其中，波浪线代表连接R3和R4的苯环。 该化合物的制备过程和治疗用途。